CAMBRIDGE, Mass.--(BUSINESS WIRE)--
InVivo Therapeutics Holdings Corp. (NVIV) today announced the
posting of the management presentation recording from the 2014 Annual
Shareholders Meeting held on July 30th, 2014. The recording
is available on the investor relations page of InVivo’s website - http://www.invivotherapeutics.com/investor-relations/
Mark Perrin, Chief Executive Officer, said, “I am very pleased with the
turnout at this year’s annual shareholders meeting. It was a great
opportunity for me and our CSO, Tom Ulich, to tell the updated InVivo
story directly to our shareholders. I’m grateful for the support and
feedback I received, and I look forward to continued interactions with
our investors and the investment community going forward.”
About InVivo Therapeutics
InVivo Therapeutics Holdings Corp. is a pioneering biomaterials and
biotechnology company with a focus on treatment of spinal cord injuries.
The company was founded in 2005 with proprietary technology co-invented
by Robert Langer, ScD., Professor at Massachusetts Institute of
Technology, and Joseph P. Vacanti, MD, who is affiliated with
Massachusetts General Hospital. In 2011 the company earned the David S.
Apple Award from the American Spinal Injury Association for its
outstanding contribution to spinal cord injury medicine. The
publicly-traded company is headquartered in Cambridge, MA. For more
details, visit, www.invivotherapeutics.com.
Brian Luque, 617-863-5535
Source: InVivo Therapeutics Holdings Corp.